{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:09:41Z","timestamp":1794971381332,"version":"4.9.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JSPS KAKENHI","award":["17K09977"],"award-info":[{"award-number":["17K09977"]}]},{"name":"JSPS KAKENHI","award":["23K07895"],"award-info":[{"award-number":["23K07895"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Lupus nephritis (LN) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE), affecting nearly half of the patients with SLE. Type I interferon (IFN) plays a central role in SLE and LN pathogenesis. This study explored the differential expression of type I IFN gene signatures (IFNGS) in renal tissues from early- and late-onset LN patients to uncover pathways linked to disease progression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Twenty-one patients with biopsy-confirmed LN were analysed. Based on the timing of LN onset, patients were classified into early-onset (n\u2009=\u200910) or late-onset (n\u2009=\u200911) groups. Clinical data, laboratory results and histological features were also obtained. RNA sequencing was performed on the renal biopsy samples to examine gene expression. Differentially expressed genes were identified using edgeR, and gene set enrichment analysis (GSEA) was used for IFNGS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with early-onset LN exhibited significantly higher anti-dsDNA titres (63.4\u2009U\/ml, P\u2009=\u20090.024) and urinary N-acetyl-\u03b2-D-glucosaminidase levels (39.4\u2009U\/l, P\u2009=\u20090.005) than those with late-onset LN (7.3\u2009U\/ml and 11.4\u2009U\/l, respectively). Hierarchical clustering identified 100 genes (50 upregulated and 50 downregulated) that differentiated the groups. GSEA revealed enrichment of type I IFN pathways in early-onset LN with prominent neutrophil chemotaxis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Early-onset LN is characterized by elevated type I IFN activity and neutrophil-driven inflammation, reflecting a more aggressive phenotype. These findings highlight the potential therapeutic targets and emphasize the importance of personalized treatment. Early modulation of type I IFN may prevent fibrosis and improve renal outcomes in early-onset LN.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf211","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:36:05Z","timestamp":1745307365000},"page":"5112-5117","source":"Crossref","is-referenced-by-count":6,"title":["Type I interferon dysregulation drives distinct pathogenic pathways in early- and late-onset lupus nephritis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8794-7106","authenticated-orcid":false,"given":"Kunihiro","family":"Ichinose","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki,","place":["Japan"]},{"name":"Department of Rheumatology, Shimane University Faculty of Medicine , Izumo,","place":["Japan"]},{"name":"Integrated Kidney Research and Advance, Shimane University Faculty of Medicine , Izumo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Cell Innovator Inc , Fukuoka,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineaki","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"2025090315123351300_keaf211-B1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"2025090315123351300_keaf211-B2","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/rheumatology\/keac641","article-title":"Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations","volume":"62","author":"Mavragani","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025090315123351300_keaf211-B3","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025090315123351300_keaf211-B4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025090315123351300_keaf211-B5","first-page":"575","article-title":"Emerging concepts of type I interferons in SLE pathogenesis and therapy","volume":"18","author":"Psarras","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025090315123351300_keaf211-B6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13075-020-02271-3","article-title":"Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort","volume":"22","author":"Ichinose","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2025090315123351300_keaf211-B7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2025090315123351300_keaf211-B8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","article-title":"Prognostic factors in lupus nephritis. Contribution of renal histologic data","volume":"75","author":"Austin","year":"1983","journal-title":"Am J Med"},{"key":"2025090315123351300_keaf211-B9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"2025090315123351300_keaf211-B10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2025090315123351300_keaf211-B11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2025090315123351300_keaf211-B12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2025090315123351300_keaf211-B13","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gkq1184","article-title":"NCBI GEO: archive for functional genomics data sets\u201410 years on","volume":"39","author":"Barrett","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2025090315123351300_keaf211-B14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s42003-019-0382-x","article-title":"Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus","volume":"2","author":"Catalina","year":"2019","journal-title":"Commun Biol"},{"key":"2025090315123351300_keaf211-B15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-015-0588-3","article-title":"Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells","volume":"17","author":"Castellano","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2025090315123351300_keaf211-B16","doi-asserted-by":"crossref","first-page":"101569","DOI":"10.1016\/j.xcrm.2024.101569","article-title":"Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE","volume":"5","author":"Gomez-Banuelos","year":"2024","journal-title":"Cell Rep Med"},{"key":"2025090315123351300_keaf211-B17","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/rheumatology\/keaa599","article-title":"Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis","volume":"60","author":"Okamoto","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025090315123351300_keaf211-B18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41584-021-00588-0","article-title":"Skin-kidney crosstalk in SLE","volume":"17","author":"Kolios","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2025090315123351300_keaf211-B19","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1016\/j.cell.2022.07.021","article-title":"Distinct transcriptome architectures underlying lupus establishment and exacerbation","volume":"185","author":"Nakano","year":"2022","journal-title":"Cell"},{"key":"2025090315123351300_keaf211-B20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf211\/63000750\/keaf211.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/9\/5112\/63000750\/keaf211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/9\/5112\/63000750\/keaf211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:12:43Z","timestamp":1756926763000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/9\/5112\/8119256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf211","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,4,24]]}}}